Jazz Pharmaceuticals Announces U.S. FDA Approval of Monday/Wednesday/Friday Intramuscular Dosing Schedule for Rylaze®
Jazz Pharmaceuticals Announces U.S. FDA Approval For Intramuscular Dosing Schedule for Rylaze Rylaze dosing option provides sustained asparaginase activity throughout the course of treatment for adult and pediatric patients with acute lymphoblastic leukemia or lymphoblastic lymphoma Jazz Pharmaceuticals plc announced…